MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.03 -0.09

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.62

Max

11.25

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

-0.54% downside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-118M

798M

Ouverture précédente

11.12

Clôture précédente

11.03

Sentiment de l'Actualité

By Acuity

67%

33%

318 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 avr. 2026, 23:36 UTC

Acquisitions, Fusions, Rachats

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion -- Update

14 avr. 2026, 23:24 UTC

Actions en Tendance

Stocks to Watch: Gloo, Broadcom, GitLab

14 avr. 2026, 22:42 UTC

Acquisitions, Fusions, Rachats

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion

14 avr. 2026, 21:32 UTC

Principaux Mouvements du Marché

GitLab Shares Rise on Expanded Google Cloud Collaboration

14 avr. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About Energy Shortage Ease -- Market Talk

14 avr. 2026, 23:34 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

14 avr. 2026, 22:54 UTC

Résultats

BRP: Amendment Mainly Leads to 25% Tariff on Total Value of Imported Snowmobiles and Majority of ORV Models, Replacing Previous 50% Tariff on Applicable Metal Content Only >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Suspending Guidance Following Amendment of Section 232 Tariffs on Steel, Aluminum and Copper Imports Into U.S., Which Came Into Effect on April 6 >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Currently Estimates Potential Incremental Tariff Cost Related to This Amendment in Excess of $500M for Remainder of Yr >DOO.T

14 avr. 2026, 22:54 UTC

Résultats

BRP: Suspends FY27 Guidance Due to Changes to U.S. Tariff Environment

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Targets Deal Completion Toward End of 3Q

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Acquisition Diversifies Portfolio; Met Coal Share to Rise to 22%

14 avr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Asset 'Strong Strategic Fit'; to Positively Add Production, Cash Flow

14 avr. 2026, 22:16 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Intends to Fund Acquisition With Cash, 5-Year Loan Facility

14 avr. 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Contingent Consideration Linked to Average Annual Prices For 5 Years

14 avr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Deal Includes Contingent Cash Consideration Up to $550 Million

14 avr. 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: Deal Includes $1.85 Billion Upfront Consideration

14 avr. 2026, 22:12 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: To Buy Kestrel Stake From EMR Capital, Adaro Capital

14 avr. 2026, 22:12 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: To Buy Kestrel Stake For Up to $2.4 Billion

14 avr. 2026, 22:10 UTC

Acquisitions, Fusions, Rachats

Yancoal Australia: to Acquire 80% Interest in Kestrel Coal Mine

14 avr. 2026, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

14 avr. 2026, 20:33 UTC

Acquisitions, Fusions, Rachats

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 avr. 2026, 20:32 UTC

Actions en Tendance

Stocks to Watch: JPMorgan, American Airlines, LVMH, BlackRock -- WSJ

14 avr. 2026, 19:59 UTC

Acquisitions, Fusions, Rachats

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

14 avr. 2026, 19:38 UTC

Résultats

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 avr. 2026, 19:27 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

14 avr. 2026, 19:21 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Retreat on Hopes for U.S.-Iran Peace Talks -- Market Talk

14 avr. 2026, 19:09 UTC

Acquisitions, Fusions, Rachats

Apple and Amazon Partner on Satellite Deal. Why It Makes Sense. -- Barrons.com

14 avr. 2026, 18:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14 avr. 2026, 18:30 UTC

Market Talk

Treasury Yields, Dollar Fall as Markets Price Higher Odds of Fed Cuts -- Market Talk

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

-0.54% baisse

Prévisions sur 12 Mois

Moyen 11 USD  -0.54%

Haut 12 USD

Bas 9 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

6 ratings

0

Achat

4

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

318 / 348Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat